Tamariki aged 5-11 years can be vaccinated against COVID-19.
The vaccine used for tamariki is a children’s version of the Pfizer vaccine, with a lower dose and smaller volume. Tamariki need two doses of the vaccine to be fully protected. These doses are given at least 8 weeks apart, this can be shortened to a minimum of 3 weeks if needed (for example if your child is starting treatment with immunosuppressants).
Many of our community vaccination centres have after-school clinics to make it easier for you and you children to get vaccinated. You can find out more about these and book online at Healthpoint.
Vaccination after COVID-19 infection
It's recommended you wait 3 months after testing positive before your first or next dose to maximise immunity. The recommendation applies to all ages and COVID-19 vaccinations in New Zealand.
Consent
Children in this age group must have a parent, caregiver or legal guardian accompany them to their appointment and provide consent for them to be vaccinated.
At your appointment, both the adult and child can ask as many questions as you like.
Preparing your tamariki for vaccination
Here are some useful tips to help prepare your tamariki for vaccination.

Let them know the vaccine will help protect them

Wear clothes that make it easy to access their upper arm

Bring a soft toy, music or phone for distraction

Encourage them to ask the vaccinator questions

Arrange a fun activity or treat for after the appointment
Talk to your vaccinator - they will help your child feel more comfortable.
Find out more about vaccinations and children.
Tamariki who turn 12 before their second dose
In September 2022 vaccination requirements for children turning 12 years old were updated. If a child turns 12 years old before their second dose, they will receive the adult dose of the COVID-19 vaccination.
An 8-week gap is recommended between the paediatric and adult doses. This change only affects those who turn 12 between receiving their first and second dose of the COVID-19 vaccine. Children under 12 are still only eligible for paediatric doses.
For more information click here